Grafa News and Videos — Page 105

Nuvini Group (NASDAQ:NVNI) reported improved financial performance for the first half of 2026, with operating income reaching R$19.6 million compared with an operating loss of R$32.0 million in the same period last year.

Johnson & Johnson (NYSE:JNJ) announced positive topline results from a pivotal Phase 3 trial evaluating CAPLYTA® (lumateperone) 42 mg once daily for the treatment of acute manic episodes in adults with bipolar I disorder.

JPMorgan's (NYSE:JPM) asset management division and Qatar Investment Authority have signed a Memorandum of Understanding for a strategic investment partnership valued at $20 billion.

ZJK Industrial (NASDAQ:ZJK) reported first-half 2026 financial results, with revenue reaching US$33.74 million for the six months ended June 30, 2026, representing a 36.6% increase compared with the prior-year period.

AbbVie (NYSE:ABBV) announced a multi-year collaboration with Iambic Therapeutics to apply artificial intelligence technologies to discover and develop small molecule therapies.

Magnachip Semiconductor (NYSE:MX) announced that Navitas Semiconductor (NASDAQ:NVTS) will make a $5 million strategic equity investment in the company.

Syntec Optics Holdings (NASDAQ:OPTX) announced an order to supply advanced optical components for U.S. Space Force infrastructure and U.S. National Reconnaissance Office satellite constellations.

Helus Pharma (NASDAQ:HELP) presented four posters on its investigational oral deuterated psilocin analog HLP003 for major depressive disorder (MDD) at Psych Congress 2026 in New Orleans.

Priority Technology Holdings (NASDAQ:PRTH) entered a definitive agreement to be acquired by an investor group led by Chairman and CEO Thomas Priore, which will purchase all outstanding shares it does not already own for $8.05 per share in cash.

Bruker (NASDAQ:BRKR) announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation valued at more than $6 million.